In late 2017, a federal watchdog unit assigned a working group to keep an eye on cryptocurrencies such as Bitcoin, and to sound an alert if those alternate currencies showed signs of becoming a risk to the stability of the US... Read more »
Another company headed by former Illumina executives has launched, fueled with a $17 million Series A round from investors including a local venture capital firm.
The new firm, Cradle Genomics, is seeking to commercialize improved non-invasive prenatal tests, which analyze blood... Read more »
In this new age of cancer immunotherapy, two versions have been approved. The first are checkpoint inhibitors, which have begun to change the way skin, lung, and other cancers are treated. The second are CAR-T cell therapies, which have... Read more »
Many companies have been adjusting to the changing workforce as millennials become a larger component of their staff rosters. Some are adapting with the help of talent management services such as 15Five, which has studied the millennial mindset.
San Francisco-based... Read more »
Broadcom is once, twice, three times a multi-billion-dollar dealmaker (well, basically) in the past year if it follows through on its reported talks to acquire Mountain View, CA-based cybersecurity giant Symantec.
Managing Director, D.E. Shaw and Co., L.P.
CEO and Co-Founder, Solazyme
Partner, Morgenthaler Ventures
President and CEO, Complete Genomics
Partner, Venrock Ventures
President and CEO, On Demand Therapeutics
Chairman and CEO, Digital Chocolate
Professor of Computer Science, UC Berkeley
Co-Founder and CEO, 23andMe
Director, Intel Capital
General Partner, Frazier Healthcare